Abstract:Introduction Gene‐corrected autologous cells provide one avenue for treating respiratory diseases, such as Cystic Fibrosis and Primary Ciliary Dyskinesia that harbor an underlying genetic defect. Basal cells are critical stem cells in the airways with the capacity to generate all cells of the respiratory epithelium. Use of these cells is limited due to inherent difficulties in gene editing and expansion in vitro . Efficient generation of basal cells from iPSCs has the potential to generate enough cells for both autologous cell therapy and for in vitro disease modelling. Building on our airway differentiation protocol, we have derived a strategy for the specification, isolation and expansion of iPSC‐derived basal cells (iBasal) improving the efficiency of generating respiratory epithelium from iPSC. Methods iPSC are cultured using a modified differentiation protocol pushing the formation of lung progenitor cells sorted on day 17 of differentiation for CD47 hi CD26 lo cells. These cells express transcription factor NKx2.1 and can be cultured in defined serum‐free media in the absence of wnt signaling. Over 4 passages we evaluated; 1) expression of basal cell markers, 2) clonality by a limited dilution clonogenic assay and by spheroid formation and 3) stem cell potential in spheroid and air‐liquid interface differentiation assays. Gene expression was compared to that of primary endogenous basal cells by bulk and single cell RNAseq, and validated by qPCR. Results Under our defined culture conditions, iBasal can be derived from NKx2.1 expressing lung progenitor cells. They are clonogenic forming colonies expressing cytokeratin 5 (krt5), p63 and integrin alpha 6 (IGTA6), acquiring more mature basal cell marker, nerve growth factor receptor (NGFR), expression after passaging when cultured on NIH3T3‐J2 feeders or in defined media. iBasal have the capacity for differentiation into a functional, tight junction forming epithelium containing both mucus secreting and motile multiciliated cells at the air liquid interface. In addition, they can form and maintain as spheroids which can also differentiate to generate airway epithelial cells. iBasal can be passaged and maintain a basal cell phenotype similar to that of paired passaged human airway basal cells. Single cell sequence data on iBasal and paired primary and cultured basal cells will provide the ultimate validation of iBasal. Conclusion We have generated iBasal from four independent iPSC lines with functional properties akin to that of primary basal cells. iBasal, therefore, provide the opportunity to generate sufficient functional and gene‐corrected autologous basal cells to develop patient specific, high throughput screening platforms overcoming the current limitations. Support or Funding Information Cystic Fibrosis Foundation FIRTH17XX0, FIRTH15XX1, NIH:NHLBI R01 HL139828‐01, Hastings Foundation This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .

Dynamic transcriptional and epigenomic reprogramming from pediatric nasal epithelial cells to induced pluripotent stem cells

Inducing Pluripotency for Disease Modeling, Drug Development and Craniofacial Applications.

Direct Reprogramming of Mouse Fibroblasts to Neural Progenitors

Direct Reprogramming of Adult Human Fibroblasts to Functional Neurons under Defined Conditions.

Epigenetic memory in induced pluripotent stem cells

Reprogrammed Astrocytes As a Potential Therapy for Neurodegenerative Disorders.

Epigenetic and Transcriptional Shifts in Human Neural Stem Cells after Reprogramming into Induced Pluripotent Stem Cells and Subsequent Redifferentiation

Efficient Generation of Lung and Airway Epithelial Cells from Human Pluripotent Stem Cells

Persistent Donor Cell Gene Expression among Human Induced Pluripotent Stem Cells Contributes to Differences with Human Embryonic Stem Cells

Understanding persistent airway obstruction in type 2 severe asthma using human induced pluripotent stem cells (iPSCs)

A Transcriptional Roadmap to the Induction of Pluripotency in Somatic Cells

The Use of Nasal Epithelial Stem/progenitor Cells to Produce Functioning Ciliated Cells in Vitro

Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system

Retinal Cell Type DNA Methylation and Histone Modifications Predict Reprogramming Efficiency and Retinogenesis in 3D Organoid Cultures

Remodeling of Epigenetic Landscape During Induced Somatic Cell Reprogramming

A combined epigenetic and non-genetic approach for reprogramming human somatic cells

Development of a bronchial epithelium model innervated by sensory neurons from human induced pluripotent stem cells

iPSC Preparation and Epigenetic Memory: Does the Tissue Origin Matter?

Induced Pluripotent Stem Cell-Derived Basal Cells Provide A Novel Source of Multilineage Airway Epithelial Cells

Nucleosome organizations in induced pluripotent stem cells reprogrammed from somatic cells belonging to three different germ layers

Genome-wide gene expression analyses reveal unique cellular characteristics related to the amenability of HPC/HSCs into high-quality induced pluripotent stem cells